Stock BIOCON BIOCON LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Biocon Limited

Equities

BIOCON

INE376G01013

Market Closed - NSE India S.E.
Other stock markets
 07:43:47 2024-06-06 am EDT 		5-day change 1st Jan Change
332.8 INR +9.01% Intraday chart for Biocon Limited +2.83% +33.29%
May. 31 Biocon Limited Receives Show Cause Notice from the Assistant Commissioner of Customs, Chennai CI
May. 24 INDIA STOCKS-Indian shares surrender gains as U.S. rate worries weigh RE

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biocon Limited Receives Show Cause Notice from the Assistant Commissioner of Customs, Chennai
CI
INDIA STOCKS-Indian shares surrender gains as U.S. rate worries weigh
RE
Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea
MT
Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc
CI
US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz
MT
Jefferies Adjusts Biocon’s Price Target to INR230 From INR250, Keeps at Underperform
MT
Biocon's Consolidated Net Profit Declines in Fiscal Q4
MT
India's Biocon posts Q4 profit fall as higher raw material costs bite
RE
Transcript : Biocon Limited, Q4 2024 Earnings Call, May 16, 2024
Biocon Limited Proposes Final Dividend for the Financial Year Ended March 31, 2024, Payable on or Before September 6, 2024
CI
Biocon Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Biocon Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda in Mexico with Medix
AQ
Biocon Signs Deal with Medix for Commercialization of Chronic Weight Management Drug in Mexico
MT
Biocon Limited Signs Semi-Exclusive Distribution and Supply Deal for the Commercialization of Generic Saxenda® (Liraglutide) in Mexico with Medix
CI
Biocon Limited Receives Demand Orders from Assistant Commissioner of State Tax Guwahati, Assam and Sales Tax Officer Class II/Avato, Ward 41, Zone 3, Delhi
CI
Biocon Limited Receives Demand Orders from the Office of Deputy State Tax Officer-1, Purasawakkam Assessment Circle, Chennai and Assistant Commissioner, Commercial Taxes Department, Visakhapatnam ­ II Division
CI
Natural Biocon (India) CFO Passes Away
MT
Biocon Limited Receives Approval from the South African Health Products Regulatory Authority for its Vertically Integrated, Complex Drug Product Tacrolimus Capsule 0.5mg, 1mg and 5mg Strengths, in South Africa
CI
India's Biocon developing its own version of Wegovy, clinical trial likely next year
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOCON Stock
  4. News Biocon Limited